OUR PROCESS

Lobbying and sound policy research is essential to our cause

See how we work

OUR EVENTS

Our events extend beyond the legislative session. Come join us.

Come join the fun

OUR TEAM

Our board member's hard work and dedication make it all happen.

Meet your advocators

Who We are. Our mission

Heart

SMPL is an organization dedicated to statewide coalition building, sound policy research, education and advocacy for substantive drug law reform. We are headquartered in the capitol of Baton Rouge where we lobby at the local and state level, but have affiliates in every major city throughout Louisiana. The SMPL board is a dynamically diverse mix of professionals who share one passion in common for making our laws for marijuana both modernized and civilized. We bring to the task a varied mix of seasoned and younger advocates, different political orientations, ethnicities, sexes, socio-economic backgrounds, birthplaces and skill sets or expertise. By going public with our growing coalition and amplifying publicly available information, we seek to help expose the ulterior motives of the vested drug warriors and undo some of the deep damage that results from the stigmatism of any non-violent fully consenting private consumption of a naturally occurring medicinal plant. learn more

Help Us Reach our Goal

Interested in helping out? SMPL is a 501c4 registered non-profit funded entirely by donations.

Donations
$
75%
Fundraiser
$
60%

Latest News Releases

Check it out: http://www.legis.la.gov/Legis/ViewDocument.aspx?d=1046579 This is how the vote went down.  Please take a moment to thank our supporters in the Senate and then place a critical call to your state representative and let them know how much we need their vote on SB 35 when it lands in the House next week.  http://www.legis.la.gov/Legis/FindMyLegislators.aspx First stop, House Judiciary and those members that need to hear from us the most: http://house.louisiana.gov/H_Cmtes/Judiciary.aspx   Thanks to each of you for all you do – this … read more

February 8th, 2017 by Tom Angell A bipartisan group of seven Republicans and six Democrats filed new Congressional legislation that would protect people who are acting in compliance with state marijuana laws from federal prosecution and punishment. Titled the “Respect State Marijuana Laws Act of 2017,” the bill adds a new provision to the Controlled Substances Act that reads: “Notwithstanding any other provision of law, the provisions of this subchapter related to marihuana shall not apply to any person acting … read more

An Israeli government committee gave an initial nod on Sunday for the export of medical marijuana in what could be a windfall for companies in Israel, widely regarded as a leader in research in the field. A government statement announcing the vote said it could take months for the legislation to make its way through parliament. In the United States, 28 states have legalized marijuana for medical use and since 2012, Colorado, Alaska, California, Maine, Massachusetts, Nevada, Oregon and Washington, … read more

February 3rd, 2017 by Tom Angell Most MassRoots readers probably already know that President Trump pledged on the campaign trail that he would respect state marijuana laws. You probably also know that Trump’s nominee to head the Justice Department has a long history of speaking out against legalization. But where do other incoming top Trump administration officials stand on cannabis? We’ve compiled everything you need to know right here. Just in case you haven’t followed all the latest news from Capitol … read more

  Two new bills to reform federal marijuana laws were just introduced in Congress, and MassRoots has an exclusive first look at the proposals. Both sponsored by Congressman Morgan Griffith (R-VA), H.R. 714 and H.R. 715 would reschedule cannabis under the Controlled Substances Act (CSA). The first bill, also known as the Legitimate Use of Medicinal Marijuana Act (LUMA), would simply move cannabis from its status under Schedule I — the most restrictive drug category under federal law — to … read more

February 1st, 2017 by Tom Angell Neil Gorsuch, President Donald Trump’s pick for the U.S. Supreme Court, has issued a few interesting marijuana rulings over the years. But Gorsuch, currently a judge on the U.S. Court of Appeals for the 10th Circuit, hasn’t ever given a clear indication of how he’d rule on big cases about conflicts between state and federal marijuana laws that might arrive before the Supreme Court in the coming years. In 2015 case, he ruled against a Colorado marijuana dispensary, … read more

By THE  New York Times EDITORIAL BOARD JAN. 17, 2017 Even as more and more states allow their residents to use marijuana, the federal government is continuing to obstruct scientists from studying whether the drug is good or bad for people’s health. A report published last week by the National Academies of Sciences, Engineering and Medicine points out that scientists who want to study cannabis have to seek approvals from federal, state and local agencies and depend on just one lab, at … read more

Recent years have seen a rapid rise in the medical and recreational use of cannabis: a broad term that can be used to describe the various products and chemical compounds (e.g., marijuana, cannabinoids) derived from different species of the cannabis plant. Despite increased cannabis use and a changing state-level policy landscape, conclusive evidence regarding the short- and long-term health effects—both harms and benefits—of cannabis use remains elusive. A lack of definitive evidence has resulted in insufficient information on the health … read more

In an effort to help improve lives through cannabinoid research, Australian philanthropist Barry Lambert and wife Joy recently donated US$3 million (AU$4.1 million) to the Thomas Jefferson University. Due to their generous donation, the school has renamed its cannabis research centre to the Lambert Center for the Study of Medicinal Cannabis and Hemp. This philanthropic move was fuelled by the condition of Barry Lambert’s granddaughter, Katelyn, who is suffering from Dravet syndrome. The condition is a type of epilepsy that … read more

Middle East By ISABEL KERSHNERDEC. 17, 2016 JERUSALEM — Israeli scientists began their pioneering research to isolate the psychoactive ingredient in marijuana with a 10-pound stash seized by the Tel Aviv police. That effort, in the 1960s, helped propel Israel to the vanguard of research into the plant’s medicinal properties and lay the foundations for a medical marijuana industry. Now the nation’s burgeoning pot business, backed by an unlikely coalition of farmers, lawyers, scientists, entrepreneurs and the country’s ultra-Orthodox health … read more

Follow by Email
Facebook
Facebook
Twitter